Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

NCT03882580 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.

NCT NCT03882580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03882580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Lead sponsor
Groupe Hospitalier Pitie-Salpetriere
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2019
Completion date
March 1, 2030
Enrollment
5,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac complication, cardiac disorder, cardiac insufficiency, cardiovascular complication, cardiovascular insufficiency, metabolic disorder, oncologic complications, vascular disorder